Literature DB >> 12616475

Littoral cell angiomatosis with poorly differentiated adenocarcinoma of the lung.

Gary L Collins1, Michael B Morgan, Frank M Taylor.   

Abstract

We report on a 64-year-old male United States Navy Veteran of World War II, one of two identical twins, diagnosed with littoral cell angiomatosis of the spleen, liver, and lymph nodes, later found to have a massive poorly differentiated adenocarcinoma involving the mediastinum, adjoining lung, and sternum with widespread metastases. Herein we include our findings at autopsy, pertinent immunohistochemical studies, and a review of the literature pertaining to littoral cell angiomatosis with comment on its association with visceral malignancies. Copyright 2003, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12616475     DOI: 10.1053/adpa.2003.50009

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  5 in total

1.  Littoral-cell angioma of the spleen: a case report.

Authors:  Angel Cosme; Angel Tejada; Luis Bujanda; Manuel Vaquero; José Luis Elorza; Evelia Ojeda; Unai Goikoetxea
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

2.  Littoral cell angiomas of the spleen associated with solid pseudopapillary tumor of the pancreas.

Authors:  Tapan Bhavsar; Congli Wang; Yajue Huang; Andreas Karachristos; Susan Inniss
Journal:  World J Gastrointest Pathophysiol       Date:  2011-06-15

3.  Littoral cell angioma of the spleen.

Authors:  P Priego; G Rodríguez Velasco; P S Griffith; V Fresneda
Journal:  Clin Transl Oncol       Date:  2008-01       Impact factor: 3.405

4.  Littoral cell angioma of the spleen in a patient with previous pulmonary sarcoidosis: a TNF-α related pathogenesis?

Authors:  Stefanie Cordesmeyer; Manfred Pützler; Ulf Titze; Harald Paulus; Matthias W Hoffmann
Journal:  World J Surg Oncol       Date:  2011-09-19       Impact factor: 2.754

5.  Littoral cell angioma (LCA) associated with liver cirrhosis.

Authors:  Hi-Gu Kim; In-Suh Park; Jung-Il Lee; Seok Jeong; Jin-Woo Lee; Kye-Suk Kwon; Don-Haeng Lee; Pum-Soo Kim; Hyung-Gil Kim; Yong-Woon Shin; Young-Soo Kim; In-Sun Ahn; Keon-Young Lee
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.